Phathom Pharmaceuticals, Inc. (PHAT) Profit Margin
Phathom Pharmaceuticals, Inc. (PHAT) gross and net profit margin history with trends. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2019-12-31 | N/A |
| 2020-12-31 | N/A |
| 2021-12-31 | N/A |
| 2022-12-31 | N/A |
| 2023-12-31 | -29558.94% |
| 2024-12-31 | -605.09% |
| 2025-12-31 | -126.35% |
How PHAT compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| HBIO | Harvard Bioscience Inc. | -65.51% |
| QTRX | Quanterix Corporation | -77.14% |
| ENTA | Enanta Pharmaceuticals Inc. | -125.36% |
| SNDX | Syndax Pharmaceuticals Inc. | -165.60% |
| AQST | Aquestive Therapeutics Inc. | -188.09% |
These are five companies in the same sector as PHAT with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Phathom Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("PHAT", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | PHAT | $8.57 | +0.23% | 2.14M |
| 3 | ||||
| 4 | ||||
| 5 |